Join us for our next Live-talk  Thursday, August 18, at 3:00 pm PST. for great conversation and compelling guests.   You can read more about Live Talk here, and  Listen to our past sessions on demand here.

News In Brief

LIVE TALK sessions are now available on Demand.  Click here to listen to past shows.

From Recordati Rare Diseases Phase III study confirms the efficacy and safety of   ISTURISA®.  achieving sustained cortisol control in the majority of patients. Read more

Good news from Amryt Pharma for acromegaly patients in Europe.  Read the release from Amryt Pharma on Mycapssa® here.

Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome.  Click here to learn more and see if you qualify. 

Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study.  To learn more about the trial and see if you qualify Read more here

Read more about clinical trials from  Xeris Pharma, Camurus AB, and  Ionis Ph

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

I'm happy to welcome Leslie Edwin, president of Cushing's Support and Research Foundation (CSRF), to our microphones. The CSRF is a leading Cushing's disease and syndrome patient support organization.

Mental health and emotional wellness are essential topics for pituitary patients, their families, and friends. This on-demand session from last Thursday's live-talk program focuses on the challenges and opportunities when considering these issues.

Subscribe & Listen

Live Talk on Demand